Nutex Health, Inc. (NUTX)

Nutex Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-45.79	-424.78	132.59	105.97	-7.12
Depreciation & Amortization	17.72	13.2	7.76	5.96	0.17
Share-Based Compensation	2.84	0.19	0	0	0.45
Other Operating Activities	26.48	462	33.08	-25.25	2.45
Operating Cash Flow	1.26	50.61	173.43	86.67	-4.04
Operating Cash Flow Growth	-97.52%	-70.82%	100.10%	-	-
Capital Expenditures	-9.5	-14.63	-36.93	-61.19	-0.08
Acquisitions	-1.74	10.3	-0.05	0	-0.56
Other Investing Activities	-	-	-	-	-0.1
Investing Cash Flow	-11.24	-4.34	-36.98	-61.19	-0.75
Share Issuance / Repurchase	0	0	0	0	4.11
Debt Issued / Paid	2.65	-5.59	-3.27	41.05	1.62
Other Financing Activities	-4.92	-42.54	-122.58	-49.02	-
Financing Cash Flow	-2.27	-48.13	-125.85	-7.97	5.73
Net Cash Flow	-12.25	-1.86	10.6	17.51	0.95
Free Cash Flow	-8.24	35.97	136.51	25.48	-4.12
Free Cash Flow Growth	-	-73.65%	435.67%	-	-
Free Cash Flow Margin	-3.33%	16.40%	41.17%	9.30%	-301.85%
Free Cash Flow Per Share	-0.18	0.83	54.86	77.34	-17.04

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).